NLR and Mortality in Coronary Heart Disease Patients
Author Information
Author(s): Qian Chen, Dai Xiao-Wei, Dong Qi-Qi, Zhang Xin-Xin, Ma Wen-Ting
Primary Institution: Department of Geriatrics, Mengcheng First People’s Hospital, Mengcheng, Anhui, China
Hypothesis
What is the relationship between the neutrophil-to-lymphocyte ratio (NLR) and mortality in patients with coronary heart disease (CHD)?
Conclusion
Elevated NLR is associated with increased risk of cardiovascular and all-cause mortality in CHD patients.
Supporting Evidence
- Patients with lower NLR had a 43% reduced risk of all-cause mortality.
- Patients with lower NLR had a 51% reduced risk of cardiovascular mortality.
- The survival rate in the high NLR group was significantly lower than in the low NLR group.
Takeaway
If you have heart disease, a higher level of a certain blood marker called NLR means you're more likely to get very sick or die.
Methodology
The study analyzed NHANES data using multivariate Cox regression and other statistical methods to assess the relationship between NLR and mortality.
Potential Biases
Unknown variables may still affect NLR despite controlling for many factors.
Limitations
Potential selection bias due to exclusion of participants with missing data and the study's observational nature.
Participant Demographics
Participants included 1625 adults with coronary heart disease, with a higher proportion of older males and non-Hispanic Whites.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI: 0.41–0.8
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website